• Lacosamide Krka 150 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  LACOSAMIDE	150 mg

  ATC: N03A N03AX N03AX18

• Lacosamide Krka 200 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  LACOSAMIDE	200 mg

  ATC: N03A N03AX N03AX18

• Lacosamide Krka 50 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  LACOSAMIDE	50 mg

  ATC: N03A N03AX N03AX18

• Lavestra HCT 100 mg/12.5 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  LOSARTAN POTASSICUM	100 mg
  HYDROCHLOROTHIAZIDE	12,5 mg

  ATC: C09D C09DA C09DA01

• Lavestra HCT 100 mg/25 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  LOSARTAN POTASSICUM	100 mg
  HYDROCHLOROTHIAZIDE	25 mg

  ATC: C09D C09DA C09DA01

• Lavestra HCT 50 mg/12.5 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  LOSARTAN POTASSICUM	50 mg
  HYDROCHLOROTHIAZIDE	12,5 mg

  ATC: C09D C09DA C09DA01

• Lenalidomide Krka 10 mg hard capsules EFG

  Form: capsules, hard

  Active substance	Dosage
  LENALIDOMIDE HYDROCHLORIDE HYDRATE	12,11 mg

  ATC: L04A L04AX L04AX04

• Lenalidomide Krka 15 mg hard capsules EFG

  Form: capsules, hard

  Active substance	Dosage
  LENALIDOMIDE HYDROCHLORIDE HYDRATE	18,16 mg

  ATC: L04A L04AX L04AX04

• Lenalidomide Krka 20 mg hard capsules EFG

  Form: capsules, hard

  Active substance	Dosage
  LENALIDOMIDE HYDROCHLORIDE HYDRATE	24,21 mg

  ATC: L04A L04AX L04AX04

• Lenalidomide Krka 25 mg hard capsules EFG

  Form: capsules, hard

  Active substance	Dosage
  LENALIDOMIDE HYDROCHLORIDE HYDRATE	30,27 mg

  ATC: L04A L04AX L04AX04

• Lenalidomide Krka 5 mg hard capsules EFG

  Form: capsules, hard

  Active substance	Dosage
  LENALIDOMIDE HYDROCHLORIDE HYDRATE	6,05 mg

  ATC: L04A L04AX L04AX04

• Levetiracetam Krka 1000 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  LEVETIRACETAM	1000 mg

  ATC: N03A N03AX N03AX14

• Levetiracetam Krka 250 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  LEVETIRACETAM	250 mg

  ATC: N03A N03AX N03AX14

• Levetiracetam Krka 500 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  LEVETIRACETAM	500 mg

  ATC: N03A N03AX N03AX14

• Levocetirizine Krka 5 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  LEVOCETIRIZINE DIHYDROCHLORIDE	5 mg

  ATC: R06A R06AE R06AE09

• Levofloxacin Krka 500 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  LEVOFLOXACIN MONOHYDRATE	512,46 mg

  ATC: J01M J01MA J01MA12

• Linezolid Krka 600 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  LINEZOLID	600,00 mg

  ATC: J01X J01XX J01XX08

• Losartan Krka 100 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  LOSARTAN POTASSICUM	100 mg

  ATC: C09C C09CA C09CA01

• Losartan Krka 25 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  LOSARTAN POTASSICUM	25 mg

  ATC: C09C C09CA C09CA01

• Losartan Krka 50 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  LOSARTAN POTASSICUM	50 mg

  ATC: C09C C09CA

• Losartan/hydrochlorothiazide Krka 100 mg/12.5 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  LOSARTAN POTASSICUM	100 mg
  HYDROCHLOROTHIAZIDE	12,5 mg

  ATC: C09D C09DA C09DA01

• Losartan/hydrochlorothiazide Krka 100 mg/25 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  LOSARTAN POTASSICUM	100 mg
  HYDROCHLOROTHIAZIDE	25 mg

  ATC: C09D C09DA C09DA01

• Losartan/hydrochlorothiazide Krka 50 mg/12.5 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  LOSARTAN POTASSICUM	50 mg
  HYDROCHLOROTHIAZIDE	12,50 mg

  ATC: C09D C09DA C09DA01

• Marixino 10 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  MEMANTINE HYDROCHLORIDE	10,00 mg

  ATC: N06D N06DX N06DX01

• Marixino 20 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  MEMANTINE HYDROCHLORIDE	20,00 mg

  ATC: N06D N06DX N06DX01

• Monkasta 10 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  MONTELUKAST SODIUM	10,4 mg

  ATC: R03D R03DC R03DC03

• Monkasta 4 mg chewable tablets EFG

  Form: tablets, chewable

  Active substance	Dosage
  MONTELUKAST SODIUM	4,16 mg

  ATC: R03D R03DC R03DC03

• Monkasta 5 mg chewable tablets EFG

  Form: tablets, chewable

  Active substance	Dosage
  MONTELUKAST SODIUM	5,2 mg

  ATC: R03D R03DC R03DC03

• Moxifloxacin Krka 400 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  Moxifloxacin Hydrochloride	454,75 mg

  ATC: J01M J01MA J01MA14

• Nebivolol Krka 5 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  NEBIVOLOL HYDROCHLORIDE	5.450 mg

  ATC: C07A C07AB C07AB12

• Nimvastid 1.5 mg hard capsules EFG

  Form: capsules, hard

  Active substance	Dosage
  RIVASTIGMINE HYDROGEN TARTRATE	2.40 mg

  ATC: N06D N06DA N06DA03

• Nimvastid 3 mg hard capsules EFG

  Form: capsules, hard

  Active substance	Dosage
  RIVASTIGMINE HYDROGEN TARTRATE	4,80 mg

  ATC: N06D N06DA N06DA03

• Nimvastid 4,5 mg hard capsules EFG

  Form: capsules, hard

  Active substance	Dosage
  RIVASTIGMINE HYDROGEN TARTRATE	7,20 mg

  ATC: N06D N06DA N06DA03

• Nimvastid 4.5 mg hard capsules EFG

  Form: capsules, hard

  Active substance	Dosage
  RIVASTIGMINE HYDROGEN TARTRATE	7.20 mg

  ATC: N06D N06DA N06DA03

• Nimvastid 6 mg hard capsules EFG

  Form: capsules, hard

  Active substance	Dosage
  RIVASTIGMINE HYDROGEN TARTRATE	9,60 mg

  ATC: N06D N06DA N06DA03

• Nimvastid 6 mg hard capsules EFG

  Form: capsules, hard

  Active substance	Dosage
  RIVASTIGMINE HYDROGEN TARTRATE	9,60 mg

  ATC: N06D N06DA N06DA03

• Nolpaza 20 mg gastro-resistant tablets EFG

  Form: tablets, enteric-coated

  Active substance	Dosage
  PANTOPRAZOLE SODIUM SESQUIHYDRATE	22,55 mg

  ATC: A02B A02BC A02BC02

• Nolpaza 40 mg gastro-resistant tablets EFG

  Form: tablets, enteric-coated

  Active substance	Dosage
  PANTOPRAZOLE SODIUM SESQUIHYDRATE	45,1 mg

  ATC: A02B A02BC A02BC02

• Olanzapine Krka 10 mg orodispersible tablets EFG

  Form: tablets, buccodispersable

  Active substance	Dosage
  OLANZAPINE	10 mg

  ATC: N05A N05AH N05AH03

• Olanzapine Krka 10 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  OLANZAPINE	10 mg

  ATC: N05A N05AH N05AH03

• Olanzapine Krka 5 mg orodispersible tablets EFG

  Form: tablets, buccodispersable

  Active substance	Dosage
  OLANZAPINE	5 mg

  ATC: N05A N05AH N05AH03

• Olanzapine Krka 5 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  OLANZAPINE	5 mg

  ATC: N05A N05AH N05AH03

• Olanzapine Krka 7.5 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  OLANZAPINE	7,5 mg

  ATC: N05A N05AH N05AH03

• Olmesartan Krka 10 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	10 mg

  ATC: C09C C09CA C09CA08

• Olmesartan Krka 20 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	20 mg

  ATC: C09C C09CA C09CA08

• Olmesartan Krka 40 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	40 mg

  ATC: C09C C09CA C09CA08

• Olmesartan/amlodipine Krka 20 mg/5 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	20 mg
  AMLODIPINE BESYLATE	6.94 mg

  ATC: C09D C09DB C09DB02

• Olmesartan/amlodipine Krka 40 mg/10 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	40 mg
  AMLODIPINE BESYLATE	13.88 mg

  ATC: C09D C09DB C09DB02

• Olmesartan/amlodipine Krka 40 mg/5 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	40 mg
  AMLODIPINE BESYLATE	6.94 mg

  ATC: C09D C09DB C09DB02

• Olmesartan/amlodipine/hydrochlorothiazide Krka 20 mg/5 mg/12.5 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	20 mg
  AMLODIPINE BESYLATE	6,94 mg
  HYDROCHLOROTHIAZIDE	12,5 mg

  ATC: C09D C09DX C09DX03